JPY 513.0
(-0.58%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.98 Billion JPY | -9.79% |
2022 | 4.41 Billion JPY | -1.31% |
2021 | 4.47 Billion JPY | -2.1% |
2020 | 4.57 Billion JPY | -7.03% |
2019 | 4.91 Billion JPY | -5.51% |
2018 | 5.2 Billion JPY | 17.13% |
2017 | 4.44 Billion JPY | 19.16% |
2016 | 3.72 Billion JPY | 2.86% |
2015 | 3.62 Billion JPY | 23.78% |
2014 | 2.92 Billion JPY | 7.2% |
2013 | 2.73 Billion JPY | -5.64% |
2012 | 2.89 Billion JPY | -15.22% |
2011 | 3.41 Billion JPY | -8.02% |
2010 | 3.71 Billion JPY | 5.69% |
2009 | 3.51 Billion JPY | -3.18% |
2008 | 3.62 Billion JPY | -14.87% |
2007 | 4.26 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 4.1 Billion JPY | 3.72% |
2024 Q1 | 3.95 Billion JPY | -0.72% |
2023 Q2 | 4.42 Billion JPY | -1.54% |
2023 Q3 | 4.25 Billion JPY | -3.81% |
2023 FY | 3.98 Billion JPY | -9.79% |
2023 Q4 | 3.98 Billion JPY | -6.39% |
2023 Q1 | 4.49 Billion JPY | 1.75% |
2022 Q4 | 4.41 Billion JPY | 2.24% |
2022 Q3 | 4.31 Billion JPY | 1.07% |
2022 FY | 4.41 Billion JPY | -1.31% |
2022 Q2 | 4.27 Billion JPY | -3.36% |
2022 Q1 | 4.42 Billion JPY | -1.17% |
2021 Q2 | 4.53 Billion JPY | -3.24% |
2021 Q3 | 4.47 Billion JPY | -1.15% |
2021 Q1 | 4.68 Billion JPY | 2.43% |
2021 FY | 4.47 Billion JPY | -2.1% |
2021 Q4 | 4.47 Billion JPY | -0.08% |
2020 Q3 | 4.48 Billion JPY | -1.69% |
2020 Q4 | 4.57 Billion JPY | 1.93% |
2020 Q1 | 4.98 Billion JPY | 1.46% |
2020 Q2 | 4.56 Billion JPY | -8.56% |
2020 FY | 4.57 Billion JPY | -7.03% |
2019 Q3 | 5.33 Billion JPY | 5.1% |
2019 Q1 | 5.28 Billion JPY | 1.66% |
2019 FY | 4.91 Billion JPY | -5.51% |
2019 Q2 | 5.07 Billion JPY | -4.01% |
2019 Q4 | 4.91 Billion JPY | -7.88% |
2018 FY | 5.2 Billion JPY | 17.13% |
2018 Q4 | 5.2 Billion JPY | 2.76% |
2018 Q3 | 5.06 Billion JPY | 9.97% |
2018 Q2 | 4.6 Billion JPY | -1.48% |
2018 Q1 | 4.67 Billion JPY | 5.21% |
2017 FY | 4.44 Billion JPY | 19.16% |
2017 Q1 | 3.97 Billion JPY | 6.6% |
2017 Q2 | 4.59 Billion JPY | 15.55% |
2017 Q3 | 4.62 Billion JPY | 0.77% |
2017 Q4 | 4.44 Billion JPY | -4.0% |
2016 Q2 | 3.43 Billion JPY | -5.13% |
2016 Q3 | 3.45 Billion JPY | 0.58% |
2016 Q1 | 3.62 Billion JPY | 0.01% |
2016 FY | 3.72 Billion JPY | 2.86% |
2016 Q4 | 3.72 Billion JPY | 7.78% |
2015 Q1 | 3.94 Billion JPY | 34.6% |
2015 FY | 3.62 Billion JPY | 23.78% |
2015 Q4 | 3.62 Billion JPY | 1.25% |
2015 Q3 | 3.57 Billion JPY | -1.6% |
2015 Q2 | 3.63 Billion JPY | -7.7% |
2014 Q1 | 2.68 Billion JPY | -1.53% |
2014 FY | 2.92 Billion JPY | 7.2% |
2014 Q2 | 2.55 Billion JPY | -5.02% |
2014 Q3 | 2.8 Billion JPY | 9.98% |
2014 Q4 | 2.92 Billion JPY | 4.22% |
2013 Q2 | 2.62 Billion JPY | -3.96% |
2013 Q3 | 2.73 Billion JPY | 4.2% |
2013 Q1 | 2.73 Billion JPY | -5.52% |
2013 Q4 | 2.73 Billion JPY | -0.2% |
2013 FY | 2.73 Billion JPY | -5.64% |
2012 Q4 | 2.89 Billion JPY | -2.06% |
2012 Q1 | 3.32 Billion JPY | -2.58% |
2012 FY | 2.89 Billion JPY | -15.22% |
2012 Q2 | 3.02 Billion JPY | -9.15% |
2012 Q3 | 2.95 Billion JPY | -2.2% |
2011 Q3 | 3.38 Billion JPY | 1.41% |
2011 Q2 | 3.33 Billion JPY | -16.98% |
2011 Q1 | 4.01 Billion JPY | 8.21% |
2011 Q4 | 3.41 Billion JPY | 0.97% |
2011 FY | 3.41 Billion JPY | -8.02% |
2010 FY | 3.71 Billion JPY | 5.69% |
2010 Q3 | 3.49 Billion JPY | 2.13% |
2010 Q2 | 3.42 Billion JPY | 0.0% |
2010 Q4 | 3.71 Billion JPY | 6.21% |
2009 FY | 3.51 Billion JPY | -3.18% |
2009 Q2 | 3.32 Billion JPY | -4.39% |
2009 Q3 | 3.48 Billion JPY | 4.83% |
2009 Q1 | 3.48 Billion JPY | -4.04% |
2009 Q4 | 3.51 Billion JPY | 0.66% |
2008 FY | 3.62 Billion JPY | -14.87% |
2008 Q4 | 3.62 Billion JPY | 0.0% |
2007 FY | 4.26 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
JINS HOLDINGS Inc. | 28.44 Billion JPY | 85.996% |
Medius Holdings Co., Ltd. | 95.08 Billion JPY | 95.81% |
Ship Healthcare Holdings, Inc. | 244.6 Billion JPY | 98.371% |
JTEC Corporation | 870.74 Million JPY | -357.522% |
Hogy Medical Co.,Ltd. | 13.91 Billion JPY | 71.378% |
Kawamoto Corporation | 11.79 Billion JPY | 66.235% |
Terumo Corporation | 504.3 Billion JPY | 99.21% |
KAINOS Laboratories, Inc. | 2.32 Billion JPY | -71.37% |
JAPAN EYEWEAR HOLDINGS CO LTD | 21.49 Billion JPY | 81.467% |
Sysmex Corporation | 186.02 Billion JPY | 97.858% |
JMS Co.,Ltd. | 43.95 Billion JPY | 90.937% |
Nakanishi Inc. | 27.51 Billion JPY | 85.52% |
Mani, Inc. | 4.84 Billion JPY | 17.774% |
Olympus Corporation | 775.55 Billion JPY | 99.486% |
HOYA Corporation | 241.35 Billion JPY | 98.349% |
SEED Co.,Ltd. | 31.92 Billion JPY | 87.521% |
Asahi Intecc Co., Ltd. | 39.65 Billion JPY | 89.952% |
Medikit Co.,Ltd. | 6.87 Billion JPY | 42.019% |
Menicon Co., Ltd. | 98 Billion JPY | 95.935% |
Sincere Co., LTD. | 2.91 Billion JPY | -36.573% |
Platz Co., Ltd. | 3.07 Billion JPY | -29.349% |
Paramount Bed Holdings Co., Ltd. | 44 Billion JPY | 90.946% |
Shofu Inc. | 8.48 Billion JPY | 53.032% |
Shigematsu Works Co., Ltd. | 7.81 Billion JPY | 49.013% |
Nipro Corporation | 849.17 Billion JPY | 99.531% |
ASO International, Inc. | 421.74 Million JPY | -844.607% |